BioCentury
ARTICLE | Clinical News

Resiniferatoxin: Phase I/II data

April 21, 2014 7:00 AM UTC

Researchers at NIH reported data from 6 patients with advanced cancer and severe refractory pain in the first 2 cohorts of an open-label, dose-escalation, U.S. Phase I/II trial showing that single int...